UPMC Childrens Hospital of Pittsburgh
Welcome,         Profile    Billing    Logout  
 9 Trials 
12 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Grange, Dorothy K
EDELIFE, NCT04980638 / 2021-002532-23: Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia

Recruiting
2
20
Europe, US
ER004
EspeRare Foundation, Pierre Fabre Medicament, Iqvia Pty Ltd
X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)
04/25
01/29
NCT05795361: Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

Available
N/A
Europe, US, RoW
Idursulfase-IT, HGT-2310, TAK-609
Takeda
Hunter Syndrome
 
 
Siminerio, Linda
NCT04678661: My Dose Coach Mobile App to Support Insulin Titration and Maintenance

Terminated
N/A
60
US
Smartphone application and web portal, My Dose Coach, Standard Insulin Therapy Education
Linda Siminerio, Sanofi
Diabetes Mellitus Type 2 - Insulin-Treated
12/22
02/23
TREAT-ED, NCT06626347: Telemedicine for Reach, Education, Access, and Treatment for Diabetes Self-Management Education and Support

Enrolling by invitation
N/A
48
US
TREAT-ED Virtual Group Diabetes Self-Management Education and Support
University of Pittsburgh, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type 1 Diabetes (T1D)
12/25
05/26
Libman, Ingrid
NCT04628481 / 2020-001926-71: A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function

Active, not recruiting
2
140
Europe, US, RoW
Ladarixin, allosteric inhibitor of CXCL8 (IL-8), CXCR1 and CXCR2 receptors, Placebo
Dompé Farmaceutici S.p.A, Dompe farmaceutici s.p.a.
Recent Onset type1 Diabetes
04/24
04/26
NCT05743244: Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)

Recruiting
2
78
US
Abrocitinib 200 MG Oral Tablet, CIBINQO, Ritlecitinib, Placebo
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Pfizer
Diabetes Mellitus, Type 1
06/26
06/27
NCT03929601: Rituximab-pvvr and Abatacept Vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes

Recruiting
2
74
US, RoW
Rituximab-pvvr, Ruxience, Abatacept, Orencia, Sterile Sodium Chloride, 0.9% Sodium Chloride Water for Injection
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH)
Type 1 Diabetes Mellitus
10/27
10/29
TN28, NCT04291703: STOP-T1D Low-Dose (ATG)

Active, not recruiting
2
101
US, RoW
Antithymocyte Globulin, Thymoglobulin, Placebo (for ATG)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diabetes Mellitus, Type 1
12/28
12/29
DVx-T1D, NCT06264258: Game-based Pediatric Diabetes Education

Recruiting
N/A
80
US
DVx-T1D™ app
Carnegie Mellon University, University of Pittsburgh
Diabetes Mellitus, Type 1, Behavior, Health
12/24
06/25
TREAT-ED, NCT06626347: Telemedicine for Reach, Education, Access, and Treatment for Diabetes Self-Management Education and Support

Enrolling by invitation
N/A
48
US
TREAT-ED Virtual Group Diabetes Self-Management Education and Support
University of Pittsburgh, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type 1 Diabetes (T1D)
12/25
05/26
Triulzi, Darrell
SCD-CARRE, NCT04084080: Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial

Recruiting
3
160
Europe, US, RoW
Red Blood Cell, Red blood cell (RBC), Standard of care
University of Pittsburgh, National Heart, Lung, and Blood Institute (NHLBI)
Sickle Cell Disease
05/26
05/26
NCT03633604: Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia

Available
N/A
US
HBOC-201, Hemopure, hemoglobin glutamer - 250 (bovine)
Jonathan H. Waters, HbO2 Therapeutics LLC
Anemia Severe
 
 
McCormick, Meghan
No trials found

Download Options